PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UBCO study explores access to psychedelics for therapeutic use

Patient perspectives suggest stigma, physician unfamiliarity can create barriers

UBCO study explores access to psychedelics for therapeutic use
2024-09-10
(Press-News.org) Feeling safe and comfortable are key when discussing your health and wellbeing with your primary care provider.

However, that feeling of comfort and safety can’t be taken for granted among many people who have turned to psychedelic substances—including psilocybin—to help control their symptoms of depression, anxiety or PTSD. Now, a team of UBC Okanagan researchers in the Irving K. Barber Faculty of Arts and Social Sciences has published a study looking into patient perspectives and potential issues when it comes to discussing psychedelics for therapeutic use with their physicians.

Dr. Michelle St. Pierre conducts research with Dr. Zach Walsh in UBC’s Therapeutic, Recreational, and Problematic Substance Use Lab. Their latest paper, published in Psychedelic Medicine, determined that concern about having an open discussion regarding psychedelic substances with a physician can create a roadblock to that conversation.

“A core component in the provision and receipt of appropriate medical care is trust and communication between patients and physicians,” she explains. “However, the stigmatization of psychedelic use for therapeutic purposes may complicate this process.”

In Canada, to legally obtain psychedelic substances for therapeutic use, a doctor must determine there is a genuine need for these psychedelics and then apply to Health Canada’s Special Access Program for their patient.

“The threshold for legal access to psychedelics for therapeutic purposes is high. Our team is aware that some patients with serious illnesses have been discouraged from pursuing legal avenues and have instead turned to unregulated providers, often due to difficulties in finding a physician willing to approve this emerging therapy.”

Fear of stigmatization, perceived lack of knowledge by their care provider and concern of damaging a long-term relationship with their physician can also stop the conversation.

The study analyzed data from approximately 800 adults who use psychedelics, with about 80 per cent endorsing their use for therapeutic purposes. Some 78 per cent of respondents reported facing barriers to access, while one-third said they had discussed using psychedelics with their doctor. For those who managed to have the conversation, 13 per cent said their doctor recommended psychedelics. Despite this, nearly 60 per cent of respondents felt less satisfied with the communication about psychedelics they’d had with their physician compared to previous conversations, and more than half felt discriminated against by their physician for raising the topic in the first place.

As policies evolve to improve access to psychedelic medicines, it’s crucial to also focus on fostering open and transparent communication between patients and physicians,” says Dr. St. Pierre. “In particular, there is a need for educational resources and guidelines to support health-care practitioners in understanding the therapeutic potential of psychedelics, especially for patients seeking new treatments for conditions like PTSD and depression.”

END

[Attachments] See images for this press release:
UBCO study explores access to psychedelics for therapeutic use

ELSE PRESS RELEASES FROM THIS DATE:

Lower diligence level linked to higher cardiovascular disease risk in type 2 diabetes

2024-09-10
People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research & Care. While certain personality traits may influence cardiovascular disease risk, adopting a healthy lifestyle is still beneficial, irrespective of diligence level, the findings show. Effective management of type 2 diabetes ...

Statins cost effective and linked to better health outcomes in older people

2024-09-10
Statin treatment is cost effective and linked to better health outcomes in older people with or without previous cardiovascular disease, although the risk reductions were substantially smaller in the latter, reports a modelling on the lifetime benefits of these drugs among the over-70s, published online in the journal Heart. The findings back consideration of these drugs for most over-70s, say the researchers. Statins are used extensively to ward off heart attacks and strokes in middle-aged people, ...

Abdominal fat linked to widespread chronic pain, especially in women

2024-09-10
Excess abdominal fat is associated with widespread chronic pain, particularly in women, finds the first study of its kind, published in the open access journal Regional Anesthesia & Pain Medicine.   Reducing excess fat deposits in the abdomen may help reduce chronic musculoskeletal pain, especially if it’s experienced at multiple body sites, suggest the researchers. Previously published research has shown that obesity is associated with musculoskeletal pain, but it’s not known if excess fat tissue is linked to chronic musculoskeletal pain and at multiple body sites, ...

Wearable brain imaging device shines a light on how babies respond in real-world situations

Wearable brain imaging device shines a light on how babies respond in real-world situations
2024-09-10
A new technology which uses harmless light waves to measure activity in babies’ brains has provided the most complete picture to date of brain functions like hearing, vision and cognitive processing outside a conventional, restrictive brain scanner, in a new study led by researchers at UCL and Birkbeck. The wearable brain imaging headgear, which was developed in collaboration with UCL spin-out Gowerlabs, found unexpected activity in the prefrontal cortex, an area of the brain that processes emotions, in response to social stimuli, appearing to confirm ...

"Cuddle hormone" oxytocin may provide pain relief and help curb harmful opioid use

2024-09-10
In the midst of America’s growing opioid crisis, a much healthier alternative to long-term pain management is emerging — one affectionately known as “the cuddle hormone,” or oxytocin. University of Florida researchers are currently investigating whether a synthetic version of this naturally-occurring human hormone can be used in conjunction with prescription drugs to help curb opioid addictions, especially in susceptible older adults. An interdisciplinary research team is conducting the two-year study, with $414,375 in funding from the National ...

Study reveals mechanism that activates glucose production in the liver in response to stress

2024-09-10
A study led by Brazilian researchers has produced a detailed description of the morphology of the nerves in the liver and how they control production of glucose when the organism is under stress. This process is known as hepatic gluconeogenesis. It is a key metabolic function of the liver that helps maintain a normal blood sugar level, especially when fasting and at times of high energy needs.  An article on the study, which entailed experiments with mice, is published in the journal Metabolism. According to the authors, the sympathetic nerves that stimulate the release of noradrenaline in the liver helped ...

Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS compared to placebo

Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS compared to placebo
2024-09-10
(San Diego, Calif.--September 9, 2024, 10:05 a.m.) -- The epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-free survival compared to placebo without any significant new adverse reactions, according to data from the POLESTAR study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer. Consolidation therapy with durvalumab is established as the standard of care for patients who do not experience disease progression following concurrent chemoradiotherapy. However, it is unknown what the specific benefit ...

Weight loss of up to 13% achieved in three months with once-a-day tablet, phase 1 trial finds

2024-09-10
Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) will hear. Amycretin, which is being developed by the Danish pharmaceutical company Novo Nordisk A/S, mimics the action of two peptide hormones in one single molecule. Amycretin is both an amylin and glucagon-like peptide-1 (GLP-1) receptor agonist. Both of these play a key role in appetite regulation ...

Time-restricted eating improves blood sugar control in adults at risk of type 2 diabetes regardless of time of day

2024-09-10
Restricting the eating window to 8 hours a day significantly improves blood glucose control in adults at risk of type 2 diabetes irrespective of whether it is earlier or later in the day, according to a randomised crossover trial to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept). “Our study found that restricting eating to a window of 8 hours per day significantly improved the daily time spent in the normal blood glucose range and reduced fluctuations in blood glucose levels. However, altering the 8-hour restricted eating period ...

Individuals with complications of diabetes are at higher risk of gum disease, Danish study finds

2024-09-10
Gum disease is more common in individuals with microvascular complications of diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) and published in The Journal of Dental Research has found. Periodontitis is a chronic inflammatory disease that affects the gums and the bones supporting the teeth. It is caused by the accumulation of bacterial plaque, and if left untreated, it can lead to the destruction of the tissues that hold the teeth in place, ultimately resulting in tooth loss. “This tooth loss can affect essential functions like chewing and speaking, while ...

LAST 30 PRESS RELEASES:

Arthropods dominate plant litter decomposition in drylands

World-renowned organic chemists attend inaugural science symposium hosted by Rice’s Global Paris Center

The trees of Miami’s future

MIT team takes a major step toward fully 3D-printed active electronics

Accelerated three-year medical school students perform as well as peers in traditional four-year programs

SwRI-developed instruments will study potential habitability of Jupiter’s moon Europa

Proposed scoring system may enhance equity in organ transplantation, increase transplant rates and improve patient survival

Survivors of childhood brain cancer are more likely to be held back in school

Updating offshore turbine designs to reflect storms’ complexity is key

Hospital strain during the COVID-19 pandemic and outcomes in older racial and ethnic minority adults

Scientists unveils key role of “selfish DNA” in early human development

Bonobos may be more vulnerable than previously thought, suggests genetics study

Scripps Research scientists discover chemical probes for previously “undruggable” cancer target

Giant Magellan telescope begins primary mirror support system testing

Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models

Political candidates who fight climate change stand to benefit in election

Stand up to Cancer announces new grants supporting pioneering research in six cancer types

Researchers awarded $1.3M to help military Veterans battling Acute Myeloid Leukemia

New hub for high-energy astrophysics — CTAO Science Data Management Centre opens at DESY in Zeuthen

JMIR publications CEO and Executive Editor Gunther Eysenbach achieves #1 ranking as most cited researcher in Medical Informatics for fifth consecutive year

ERC grant for groundbreaking wearable health tech

NIH announces winners of prize competition to improve postpartum maternal health and health equity through innovative diagnostics

APS and SPR honor Dr. Cynthia F. Bearer with the 2025 Mary Ellen Avery Neonatal Research Award

Election delays and voter trust

US air pollution monitoring network has gaps in coverage, say researchers

Continuous monitoring of fatigue in factory workers

Farmer ants’ wearable bacteria

Political polarization and trust

Study uncovers how silkworm moth's odor detection may improve robotics

New study links obesity to elevated hypertension risk among young middle eastern women

[Press-News.org] UBCO study explores access to psychedelics for therapeutic use
Patient perspectives suggest stigma, physician unfamiliarity can create barriers